UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)
Alcentra Capital Corporation |
(Name of Issuer) |
|
Common Stock, par value $0.001 per share |
(Title of Class of Securities) |
|
01374T102 |
(CUSIP Number) |
The Bank of New York Mellon Corporation
One Wall Street
New York, New York 10286 |
(Name, Address and Telephone Number of Person Authorized |
to Receive Notices and Communications) |
May
5, 2015 |
(Date of Event Which Requires Filing of this Statement) |
If the filing person has previously filed a
statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because
of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.
The information required on the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP
No. 01374T102 |
SCHEDULE 13D |
Page 1 of 4 |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
THE BANK OF NEW YORK MELLON CORPORATION
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY
|
4 |
SOURCE OF FUNDS
OO |
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
|
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
0 |
8 |
SHARED VOTING POWER
3,053,794 |
9 |
SOLE DISPOSITIVE POWER
0 |
10 |
SHARED DISPOSITIVE POWER
3,061,049 |
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,061,049 |
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
¨ |
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
22.6% |
14 |
TYPE OF REPORTING PERSON
CO; HC |
CUSIP
No. 01374T102 |
SCHEDULE 13D |
Page 2 of 4 |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
BNY MELLON, NATIONAL ASSOCIATION
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY
|
4 |
SOURCE OF FUNDS
OO |
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
|
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
0 |
8 |
SHARED VOTING POWER
1,099,851 |
9 |
SOLE DISPOSITIVE POWER
0 |
10 |
SHARED DISPOSITIVE POWER
1,107,106 |
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,107,106 |
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
¨ |
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.2% |
14 |
TYPE OF REPORTING PERSON
BK |
CUSIP
No. 01374T102 |
|
Page 3 of 4 |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
BNY ALCENTRA GROUP HOLDINGS, INC.
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY
|
4 |
SOURCE OF FUNDS
OO |
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
|
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
0 |
8 |
SHARED VOTING POWER
1,953,943 |
9 |
SOLE DISPOSITIVE POWER
0 |
10 |
SHARED DISPOSITIVE POWER
1,953,943 |
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,953,943 |
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
¨ |
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.5% |
14 |
TYPE OF REPORTING PERSON
CO; IA |
CUSIP
No. 01374T102 |
|
Page 4 of 4 |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ALCENTRA INVESTMENTS LIMITED
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY
|
4 |
SOURCE OF FUNDS
OO |
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
|
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
0 |
8 |
SHARED VOTING POWER
1,475,620 |
9 |
SOLE DISPOSITIVE POWER
0 |
10 |
SHARED DISPOSITIVE POWER
1,475,620 |
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,475,620 |
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
¨ |
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.9% |
14 |
TYPE OF REPORTING PERSON
CO; IA |
INTRODUCTORY NOTE
This
Amendment No. 2 to Schedule 13D (“Amendment No. 2”) is being filed to update information set forth in the initial
Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2015 (the “Original
Schedule 13D”) and amended by Amendment No. 1 to Schedule 13D filed with the SEC on April 30, 2015 (“Amendment
No. 1” and together with the Original Schedule 13D, the “Schedule 13D”), filed to report the beneficial
ownership of shares of common stock, par value $0.001 per share of Alcentra Capital Corporation, a Maryland corporation (the “Issuer”),
by each of the reporting persons named in such Schedule 13D (each, individually, a “Reporting Person” and collectively
the “Reporting Persons”). Except as herein amended or supplemented, all other information in the Schedule 13D
is as set forth therein.
Explanatory
Note: Information contained
in this Amendment No. 2 reflects the Reporting Persons’ beneficial ownership as of May 5, 2015.
| Item 3. | Source and Amount of Funds or Other Consideration |
Item 3 of the Schedule 13D is hereby amended to add the
following:
Between April 29, 2015 and May 5, 2015, Alcentra NY,
LLC purchased 4,983 shares of the Issuer’s common stock on the open market for an aggregate purchase price
of $68,816.98 and Alcentra Ltd. purchased 18,718 shares of the Issuer’s common stock on the open market for an
aggregate purchase price of $258,492.10. Alcentra Ltd. is indirectly wholly owned by The Bank of New York Mellon
Corporation.
| Item 4. | Purpose of Transaction |
Item 4 of the Schedule 13D is hereby amended to add the
following:
In accordance with the March 2015 Purchase
Program, between April 29, 2015 and May 5, 2015, Alcentra NY, LLC acquired 4,983 shares of the Issuer’s common
stock on the open market for an aggregate purchase price of $68,816.98 and Alcentra Ltd. acquired 18,718 shares of the
Issuer’s common stock on the open market for an aggregate purchase price of $258,492.10.
| Item 5. | Interest in Securities of the Issuer |
Items 5(a) and 5(b) of the Schedule 13D are hereby amended
and restated in their entirety as follows:
The percentages set forth below and on pages 1 through
4 above were calculated based on 13,516,766 shares of the Issuer’s common stock outstanding as of March 17, 2015, as disclosed
in the Issuer’s amended annual report on Form 10-K/A filed with the SEC on March 18, 2015.
(a)(i) The Bank of New York Mellon Corporation may
be deemed to beneficially own 3,061,049, or 22.6%, of the Issuer’s outstanding shares of common stock; (ii) BNY Mellon,
National Association may be deemed to beneficially own 1,107,106, or 8.2%, of the Issuer’s outstanding shares of common
stock; (iii) BNY Alcentra Group Holdings, Inc. may be deemed to beneficially own 1,953,943, or 14.5%, of the Issuer’s
outstanding shares of common stock; and (iv) Alcentra Investments Limited may be deemed to beneficially own 1,475,620, or
10.9%, of the Issuer’s outstanding shares of common stock.
(b)(i) The Bank of New York Mellon Corporation
shares voting power with respect to 3,053,794 of the Issuer’s shares of common stock held by Alcentra NY, LLC, Alcentra
Ltd., Alcentra Investments Limited, BNY Mellon Global Credit Alternatives Fund and BNY Mellon National Association and shares
dispositive power with respect to 3,061,049 of the Issuer’s shares of common stock held by Alcentra NY, LLC, Alcentra
Ltd., Alcentra Investments Limited, BNY Mellon Global Credit Alternatives Fund and BNY Mellon National Association.
(ii) BNY Mellon, National Association shares
voting power with respect to 1,099,851 shares of the Issuer’s shares of common stock held by clients of its wealth
management branch and dispositive power with respect to 1,107,106 shares of the Issuer’s shares of common stock held by
clients of its wealth management branch.
(iii) BNY Alcentra Group Holdings, Inc. shares voting
and dispositive power with respect to 1,953,943 of the Issuer’s shares of common stock held by Alcentra NY, LLC, Alcentra
Ltd., Alcentra Investments Limited and BNY Mellon Global Credit Alternatives Fund.
(iv) Alcentra Investments Limited shares voting and dispositive
power with respect to 1,475,620 of the Issuer’s shares of common stock.
Item 5(c) of the Schedule 13D is hereby amended to add
the following:
(c) Since April 28, 2015, the date as of which the
Reporting Persons’ beneficial ownership was reported in Amendment No. 1, Alcentra NY, LLC has purchased a total of
4,983 of the Issuer’s shares of common stock which are reported as beneficially owned by The Bank of New York
Mellon Corporation and BNY Alcentra Group Holdings, Inc. and Alcentra Ltd. has purchased a total of 18,718 of the
Issuer’s shares of common stock which are reported as beneficially owned by The Bank of New York Mellon Corporation and
BNY Alcentra Group Holdings, Inc. Please see the chart below detailing the date, price and number of shares purchased in
connection with each acquisition made since the Schedule 13D. Alcentra NY, LLC and Alcentra Ltd. made all such acquisitions
in the open market.
Trade Date |
Settlement Date |
Alcentra NY, LLC |
Alcentra Ltd. |
Total Shares |
Price |
Amount |
4/29/2015 |
5/2/2015 |
1,076 |
4,024 |
5,100 |
$ 13.7216 |
$69,980.16 |
4/30/2015 |
5/5/2015 |
1,492 |
5,576 |
7,068 |
$ 13.8152 |
$97,645.83 |
5/1/2015 |
5/6/2015 |
1,107 |
4,138 |
5,245 |
$ 13.9293 |
$73,059.18 |
5/4/2015 |
5/7/2015 |
211 |
878 |
1,089 |
$ 13.7000 |
$14,919.30 |
5/5/2015 |
5/8/2015 |
1,097 |
4,102 |
5,199 |
$ 13.7920 |
$71,704.61 |
In addition to the transactions listed above, since
April 28, 2015, certain clients of the wealth management branch of BNY Mellon, National Association have engaged in
transactions whereby the shares previously held in a wealth management account were transferred, sold, or otherwise disposed
of by certain wealth management clients.
| Item 6. | Contracts, Arrangements, Understandings or Relationships
with Respects to Securities of the Issuer |
The information contained in Items 4 and 5 are incorporated
herein by reference. Other than as described elsewhere in this Statement, the Reporting Persons have no understandings, arrangements,
relationships or contracts relating to the Issuer’s shares of common stock which are required to be described hereunder.
SIGNATURES
After reasonable inquiry and to the best of
his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete
and correct.
Dated: May 7, 2015
|
THE BANK OF NEW YORK MELLON CORPORATION |
|
|
|
|
By: |
/s/ Ivan Arias |
|
|
Name: Ivan Arias |
|
|
Title: Attorney-In-Fact for |
|
|
The Bank of New York Mellon Corporation |
|
|
|
|
BNY MELLON, NATIONAL ASSOCIATION |
|
|
|
|
By: |
/s/ Ivan Arias |
|
|
Name: Ivan Arias |
|
|
Title: Attorney-In-Fact for |
|
|
BNY Mellon, National Association |
|
|
|
|
BNY ALCENTRA GROUP HOLDINGS, INC. |
|
|
|
|
By: |
/s/ Robert Bennett |
|
|
Name: Robert Bennett |
|
|
Title: Authorized Person |
|
|
|
|
ALCENTRA INVESTMENTS LIMITED |
|
|
|
|
By: |
/s/ Robert Bennett |
|
|
Name: Robert Bennett |
|
|
Title: Authorized Person |
Alcentra Capital (NASDAQ:ABDC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alcentra Capital (NASDAQ:ABDC)
Historical Stock Chart
From Jul 2023 to Jul 2024